Thursday, January 7, 2010

FDA approves generic version of Aricept

There might soon be a potentially cheaper diagnosis option for those suffering from Alzheimer's disease. The FDA recently authorized a general chronicle of Aricept (donepezil) in a form of a tablet which dissolves in a mouth. The drug helps to treat a insanity which can result from Alzheimer's, as well as a orally dissolving regulation might assistance older adults who have worry swallowing.

Eisai, a company which manufactures Aricept, says which their patent upon a drug is in outcome until Nov 2010.

People considering taking donepezil should know which intensity side effects embody diarrhea, nausea, seizures, vomiting, gastrointestinal bleeding, as well as bladder problems, among others. Talk to your doctor about either this drug is right for you.

FDA approves general chronicle of Aricept originally appeared upon About.com Alzheimers Disease upon Wednesday, January 6th, 2010 at 10:16:08.

Permalink | Comment | Email this


No comments:

Post a Comment